{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:10:56Z","timestamp":1788135056745,"version":"build-2803163510"},"reference-count":80,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T00:00:00Z","timestamp":1644451200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005010","name":"AIRC","doi-asserted-by":"publisher","award":["21198"],"award-info":[{"award-number":["21198"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Oncology"],"abstract":"<jats:p>Diffuse large B-cell lymphoma (DLBCL) represents the most frequent type of non-Hodgkin lymphoma. Globally, DLBCL is an aggressive disease, requiring an accurate diagnosis and prompt treatment. The diagnosis is often made on biopsy samples of a nodal mass, however, approximately 40% of DLBCL cases arise at extranodal sites. The most common extranodal site is the gastrointestinal tract, however any extranodal area may be primarily involved. Primary urinary bladder lymphoma represents only 0.2% of extranodal non-Hodgkin lymphomas, whereas secondary involvement of the urinary bladder by a systemic lymphoma is a more common event. Despite being rare, DLBCL is considered to represent the predominant primary urinary bladder lymphoma. The majority of cases reported in the bladder belong to the DLBCL, NOS group, and there are only rare cases of EBV-positive DLBCL, NOS. In this review, we summarize the current knowledge on DLBCL primarily occurring in the urinary bladder, with the aim of increasing clinician and pathologist awareness on this aggressive lymphoma rarely arising in the urinary bladder. Additionally, we focus on those entities which should be taken into consideration in the differential diagnosis, highlighting potential diagnostic pitfalls.<\/jats:p>","DOI":"10.3390\/curroncol29020081","type":"journal-article","created":{"date-parts":[[2022,2,11]],"date-time":"2022-02-11T02:37:46Z","timestamp":1644547066000},"page":"956-968","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Primary Diffuse Large B-Cell Lymphoma of the Urinary Bladder: Update on a Rare Disease and Potential Diagnostic Pitfalls"],"prefix":"10.3390","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8733-9933","authenticated-orcid":false,"given":"Magda","family":"Zanelli","sequence":"first","affiliation":[{"name":"Pathology Unit, Azienda USL-IRCCS di Reggio Emilia, 42123 Reggio Emilia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Sanguedolce","sequence":"additional","affiliation":[{"name":"Pathology Unit, Policlinico Riuniti, University of Foggia, 71122 Foggia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9841-7856","authenticated-orcid":false,"given":"Maurizio","family":"Zizzo","sequence":"additional","affiliation":[{"name":"Surgical Oncology Unit, Azienda USL-IRCCS di Reggio Emilia, 42123 Reggio Emilia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2299-5160","authenticated-orcid":false,"given":"Andrea","family":"Palicelli","sequence":"additional","affiliation":[{"name":"Pathology Unit, Azienda USL-IRCCS di Reggio Emilia, 42123 Reggio Emilia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Pellegrini","sequence":"additional","affiliation":[{"name":"Pathology Unit, Azienda Ospedaliera Santa Maria di Terni, University of Perugia, 05100 Terni, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Farinacci","sequence":"additional","affiliation":[{"name":"Pathology Unit, Azienda Ospedaliera Santa Maria di Terni, University of Perugia, 05100 Terni, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Soriano","sequence":"additional","affiliation":[{"name":"Gastroenterology Division, Azienda USL-IRCCS di Reggio Emilia, 42123 Reggio Emilia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Froio","sequence":"additional","affiliation":[{"name":"Pathology Unit, Azienda USL-IRCCS di Reggio Emilia, 42123 Reggio Emilia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Cormio","sequence":"additional","affiliation":[{"name":"Department of Urology and Renal Transplantation, University of Foggia, 71122 Foggia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Carrieri","sequence":"additional","affiliation":[{"name":"Department of Urology and Renal Transplantation, University of Foggia, 71122 Foggia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Cavazza","sequence":"additional","affiliation":[{"name":"Pathology Unit, Azienda USL-IRCCS di Reggio Emilia, 42123 Reggio Emilia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Merli","sequence":"additional","affiliation":[{"name":"Hematology Unit, Azienda USL-IRCCS di Reggio Emilia, 42123 Reggio Emilia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano A.","family":"Pileri","sequence":"additional","affiliation":[{"name":"Haematopathology Division, European Institute of Oncology-IEO IRCCS Milan, 20141 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Ascani","sequence":"additional","affiliation":[{"name":"Pathology Unit, Azienda Ospedaliera Santa Maria di Terni, University of Perugia, 05100 Terni, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,2,10]]},"reference":[{"key":"ref_1","unstructured":"WHO Classification of Tumours Editorial Board (2017). WHO Classification of Tumours Haematopoietic and Lymphoid Tissues, IARC. [4th ed.]."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1023\/A:1008282818705","article-title":"Primary extranodal non-Hodgkin\u2019s lymphomas. Part 1: Gastrointestinal, cutaneous and genitourinary lymphomas","volume":"8","author":"Zucca","year":"1997","journal-title":"Ann. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1464-410X.1953.tb09253.x","article-title":"Primary lymphosarcoma of urinary bladder","volume":"25","author":"Jacobs","year":"1953","journal-title":"Br. J. Urol."},{"key":"ref_4","first-page":"5","article-title":"Primary lymphoma of the urinary bladder presenting as a large pelvic mass","volume":"71","author":"Sommezer","year":"2002","journal-title":"J. Pak. Med. Assoc."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1259\/bjr\/66130737","article-title":"Imaging findings of a primary bladder maltoma","volume":"84","author":"Maninderpal","year":"2011","journal-title":"Br. J. Radiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.amsu.2020.05.045","article-title":"Primary extranodal non-Hodgkin\u2019s lymphoma of urinary bladder presenting as a bladder tumor: A case report","volume":"56","author":"Bhutani","year":"2020","journal-title":"Ann. Med. Surg."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1038\/modpathol.2009.65","article-title":"Lymphoid neoplasms of the urinary tract and male genital organs: A clinicopathological study of 40 cases","volume":"22","author":"Schniederjan","year":"2009","journal-title":"Mod. Pathol."},{"key":"ref_8","first-page":"6989","article-title":"Primary urinary tract lymphoma: Rare but aggressive","volume":"37","author":"Lontos","year":"2017","journal-title":"Anticancer Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"327917","DOI":"10.1155\/2014\/327917","article-title":"Lymphoma of the urinary bladder","volume":"2014","author":"Venyo","year":"2014","journal-title":"Adv. Urol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1080\/10428190500079829","article-title":"Primary bladder lymphoma: Management and outcome of 12 patients with a review of the literature","volume":"46","author":"Hughes","year":"2005","journal-title":"Leuk. Lymphoma"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1136\/jcp.53.6.458","article-title":"Malignant lymphoma of the urinary bladder: A clinicopathological study of 11 cases","volume":"53","author":"Bates","year":"2000","journal-title":"J. Clin. Pathol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"268","DOI":"10.4103\/0974-7796.152947","article-title":"Primary bladder lymphoma, diffuse large B-cell type: Case report and literature review of 26 cases","volume":"7","author":"Simpson","year":"2015","journal-title":"Urol. Ann."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.2169\/internalmedicine.48.2110","article-title":"Primary diffuse large B-cell lymphoma of the bladder","volume":"48","author":"Hayashi","year":"2009","journal-title":"Inter. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"609882","DOI":"10.3389\/fonc.2021.609882","article-title":"Primary diffuse large B-cell lymphoma of the urinary tract: A population based analysis","volume":"11","author":"Liu","year":"2021","journal-title":"Front. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1097\/00000478-199711000-00007","article-title":"Malignant lymphoma of the bladder: Evidence from 36 cases that low-grade lymphoma of the malt-type is the most common bladder lymphoma","volume":"21","author":"Kempton","year":"1997","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/ajh.23638","article-title":"Sites of extranodal involvement are prognostic in patients with diffuse large B-cell lymphoma in the rituximab era: An analysis of the surveillance, epidemiology and end results data base","volume":"89","author":"Castillo","year":"2014","journal-title":"Am. J. Hematol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/annonc\/mdg004","article-title":"Primary extranodal non-Hodgkin\u2019s lymphoma (NHL): The impact of alternative definitions tested by Comprehensive Cancer Centre West population-based NHL registry","volume":"14","author":"Krol","year":"2003","journal-title":"Ann. Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1177\/1066896914536223","article-title":"Anaplastic lymphoma kinase-positive large B-cell lymphoma: Description of a case with an unexpected clinical outcome","volume":"23","author":"Zanelli","year":"2015","journal-title":"Int. J. Surg. Pathol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Zanelli, M., Zizzo, M., Montanaro, M., Gomes, V., Martino, G., De Marco, L., Orcioni, G.F., Martelli, M.P., and Ascani, S. (2019). Fibrin- associated large B-cell lymphoma: First case report within a cerebral artery aneurysm and literature review. BMC Cancer, 19.","DOI":"10.1186\/s12885-019-6123-1"},{"key":"ref_20","first-page":"503","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling","volume":"403","author":"Alizadeh","year":"2000","journal-title":"Nat. Cell. Biol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1056\/NEJMoa012914","article-title":"The use of molecular profiling to predict survival after chemotherapy for diffuse large B-cell lymphoma","volume":"346","author":"Rosenwald","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/ajh.25460","article-title":"Diffuse large B-cell lymphoma: 2019 update on diagnosis, risk stratification and treatment","volume":"94","author":"Liu","year":"2019","journal-title":"Am. J. Hematol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1053\/j.seminhematol.2015.01.006","article-title":"The histological classification of diffuse large B-cell lymphomas","volume":"52","author":"Xie","year":"2015","journal-title":"Semin. Hematol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/ajh.26151","article-title":"2021 update on Diffuse large B-cell lymphoma: A review of current data and potential applications on risk stratification and management","volume":"96","author":"Barta","year":"2021","journal-title":"Am. J. Hematol."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Pileri, S.A., Tripodo, C., Melle, F., Motta, G., Tabanelli, V., Fiori, S., Vegliante, M.C., Mazzara, S., Ciavarella, S., and Derenzini, E. (2021). Predictive and prognostic molecular factors in diffuse large B-cell lymphomas. Cells, 10.","DOI":"10.3390\/cells10030675"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","article-title":"Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray","volume":"103","author":"Hans","year":"2004","journal-title":"Blood"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"5494","DOI":"10.1158\/1078-0432.CCR-09-0113","article-title":"A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy","volume":"15","author":"Choi","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1038\/leu.2012.83","article-title":"Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: A report from the International DLBCL Rituximab-CHOP Consortium Program Study","volume":"26","author":"Visco","year":"2012","journal-title":"Leukemia"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"22014","DOI":"10.18632\/oncotarget.15782","article-title":"Cell-of-origin of diffuse large B-cell lymphomas determined by the Lymph2Cx assay: Better prognostic indicator than Hans algorithm","volume":"8","author":"Yoon","year":"2017","journal-title":"Oncotarget"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa1801445","article-title":"Genetics and pathogenesis of Diffuse large B-cell lymphoma","volume":"378","author":"Schmitz","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"129","DOI":"10.4103\/0970-1591.45552","article-title":"Epstein-Barr virus positive B-cell lymphoproliferative disorder\/polymorphous B-cell lymphoma of the urinary bladder: A case report with review of the literature","volume":"25","author":"Sundaram","year":"2009","journal-title":"Indian J. Urol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"e215","DOI":"10.1016\/j.clgc.2015.12.028","article-title":"Spontaneous regression of Epstein-Barr virus-positive primary diffuse large B-cell lymphoma of the urinary bladder after the cessation of enzalutamide","volume":"14","author":"Ogihara","year":"2016","journal-title":"Clin. Genitourin. Cancer"},{"key":"ref_33","unstructured":"Swerdlow, S.H., Campo, E., Harris, N.L., Jaffe, E.S., Pileri, S.A., Stein, H., Thiele, J., and Vardiman, J.W. (2008). WHO Classification of Tumours of Haematopoietic and Lymphoid Tissue, IARC."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"5124","DOI":"10.1158\/1078-0432.CCR-06-2823","article-title":"Age-related EBV-associated B-cell lymphoproliferative disorders constitute a distinct clinicopathologic group: A study of 96 patients","volume":"13","author":"Oyama","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1182\/blood-2015-02-630632","article-title":"EBV-positive large B-cell lymphomas in young patients: A nodal lymphoma with evidence for a tolerogenic immune environment","volume":"126","author":"Nicolae","year":"2015","journal-title":"Blood"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.humpath.2015.01.011","article-title":"Epstein-Barr virus-positive diffuse large B-cell lymphoma in children: A disease reminiscent of Epstein Barr virus-positive diffuse large B-cell lymphoma of the elderly","volume":"46","author":"Uccini","year":"2015","journal-title":"Hum. Pathol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"4726","DOI":"10.1182\/blood-2010-12-323238","article-title":"Age-related EBV associated lymphoproliferative disorders in the western population: A spectrum of reactive lymphoid hyperplasia and lymphoma","volume":"117","author":"Dojcinov","year":"2011","journal-title":"Blood"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1097\/PAS.0000000000001499","article-title":"Reappraisal of primary Epstein-Barr virus (EBV)-positive diffuse large B-cell lymphoma of the gastrointestinal tract","volume":"44","author":"Miyagi","year":"2020","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Zanelli, M., Sanguedolce, F., Palicelli, A., Zizzo, M., Martino, G., Caprera, C., Fragliasso, V., Soriano, A., Valle, L., and Ricci, S. (2021). EBV-driven lymphoproliferative disorders and lymphomas of the gastrointestinal tract: A spectrum of entities with a common denominator (Part 1). Cancers, 13.","DOI":"10.3390\/cancers13184578"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1002\/ajh.25112","article-title":"EBV-positive large B-cell lymphoma, not otherwise specified: 2018 update on diagnosis, risk-stratification and management","volume":"93","author":"Castillo","year":"2018","journal-title":"Am. J. Hematol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/cas.12389","article-title":"Gene expression profiling of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly reveals characteristic oncogenic pathways","volume":"105","author":"Kato","year":"2014","journal-title":"Cancer Sci."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1097\/01.MP.0000081726.49886.CF","article-title":"Expression of the B-cell proliferation marker MUM1 by melanocytic lesions and comparison with S100, gp100 (HMB45), and MelanA","volume":"16","author":"Sundram","year":"2003","journal-title":"Mod. Pathol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1159\/000514759","article-title":"Non-muscle invasive bladder cancer with variant histology: Biological features and clinical implications","volume":"99","author":"Sanguedolce","year":"2021","journal-title":"Oncology"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0022-5347(01)63727-3","article-title":"Bladder carcinoma with lymphoepithelioma-like differentiation: A report of 9 cases","volume":"159","author":"Holmang","year":"1998","journal-title":"J. Urol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1007\/s004280000378","article-title":"Lymphoepithelioma-like carcinoma of the urinary bladder: A clinicopathologic study of 13 cases","volume":"438","author":"Luque","year":"2001","journal-title":"Virchows Arch."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/path.1231","article-title":"Differential expression of p63 isoforms in normal tissue and neoplastic cells","volume":"198","author":"Nylander","year":"2002","journal-title":"J. Pathol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/01.pai.0000142160.52670.ce","article-title":"Expression of p63 in diffuse large B-cell lymphoma","volume":"13","author":"Hedvat","year":"2005","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1136\/jcp.2008.059519","article-title":"p63 protein expression in high risk diffuse large B-cell lymphoma","volume":"62","author":"Neto","year":"2009","journal-title":"J. Clin. Pathol."},{"key":"ref_49","first-page":"4348208","article-title":"A case of p63 positive diffuse large B cell lymphoma of the bladder","volume":"2016","author":"Deel","year":"2016","journal-title":"Case Rep. Hematol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"153611","DOI":"10.1016\/j.prp.2021.153611","article-title":"Role of GATA 3 in tumor diagnosis: A review","volume":"226","author":"Najafabadi","year":"2021","journal-title":"Pathol. Res. Pract."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0002-9440(10)62238-9","article-title":"Expression of the T-cell transcription factors, GATA-3 and T-bet, in the neoplastic cells of Hodgkin lymphomas","volume":"166","author":"Atayar","year":"2005","journal-title":"Am. J. Pathol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"65284","DOI":"10.18632\/oncotarget.11673","article-title":"GATA3 expression correlates with poor prognosis and tumor-associated macrophage infiltration in peripheral T cell lymphoma","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1182\/blood.V89.4.1413","article-title":"Plasmablastic lymphomas of the oral cavity: A new entity associated with the human immunodeficiency virus infection","volume":"89","author":"Delecleuse","year":"1997","journal-title":"Blood"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"e22335","DOI":"10.1097\/MD.0000000000022335","article-title":"Oral plasmablastic lymphoma: A case report","volume":"99","author":"Zizzo","year":"2020","journal-title":"Medicine"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1097\/PAS.0000000000000234","article-title":"Clinicopathologic comparison of plasmablastic lymphoma in HIV-positive, immunocompetent and posttransplant patients single-center series of 25 cases and meta-analysis of 277 reported cases","volume":"38","author":"Morscio","year":"2014","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1182\/blood-2014-10-567479","article-title":"The biology and treatment of plasmablastic lymphoma","volume":"125","author":"Castillo","year":"2015","journal-title":"Blood"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.5858\/arpa.2016-0232-RA","article-title":"Plasmablastic lymphoma a review of clinicopathologic features and differential diagnosis","volume":"140","author":"Harmon","year":"2016","journal-title":"Arch. Pathol. Lab. Med."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.prp.2015.09.012","article-title":"Unique presentation of a plasmablastic lymphoma superficially involving the entire large bowel","volume":"211","author":"Zanelli","year":"2015","journal-title":"Pathol. Res. Pract."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"152973","DOI":"10.1016\/j.prp.2020.152973","article-title":"Clinical, pathological and molecular features of plasmablastic lymphoma arising in the gastrointestinal tract: A review and reappraisal","volume":"216","author":"Sanguedolce","year":"2020","journal-title":"Pathol. Res. Pract."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.anndiagpath.2011.02.002","article-title":"Plasmablastic lymphoma clinically presenting in the urinary tract","volume":"16","author":"Tille","year":"2012","journal-title":"Ann. Diagn. Pathol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"72","DOI":"10.5414\/CNCS110339","article-title":"Light chain cast nephropathy caused by plasmablastic lymphoma of the bladder","volume":"9","author":"Jafarizade","year":"2021","journal-title":"Clin. Nephrol. -Case Stud."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1056\/NEJM199505043321802","article-title":"Kaposi\u2019s sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body cavity-based lymphomas","volume":"332","author":"Cesarman","year":"1995","journal-title":"NEJM"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Zanelli, M., Sanguedolce, F., Zizzo, M., Palicelli, A., Bassi, M.C., Santandrea, G., Martino, G., Soriano, A., Caprera, C., and Corsi, M. (2021). Primary effusion lymphoma occurring in the setting of transplanted patients: A systematic review of a rare, life-threatening post-transplantation occurrence. BMC Cancer, 21.","DOI":"10.1186\/s12885-021-08215-7"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1007\/s00277-020-04024-3","article-title":"Germinotropic lymphoproliferative disorder: A systematic review","volume":"99","author":"Zanelli","year":"2020","journal-title":"Ann. Hematol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1097\/01.pas.0000138177.10829.5c","article-title":"KSHV-positive solid lymphomas represent an extra-cavitary variant of primary effusion lymphoma","volume":"28","author":"Chadburn","year":"2004","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.anndiagpath.2012.03.004","article-title":"Extracavitary\/solid variant of primary effusion lymphoma","volume":"16","author":"Kim","year":"2012","journal-title":"Ann. Diagn. Pathol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1097\/PAS.0b013e31825b38ec","article-title":"Extracavitary KSHV-associated large B-cell lymphoma: A distinct entity or a subtype of primary effusion lymphoma? Study of 9 cases and review of an additional 43 cases","volume":"36","author":"Pan","year":"2012","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/bjh.16196","article-title":"Extracavitary primary effusion lymphoma in a post-transplantation patient","volume":"187","author":"Zanelli","year":"2019","journal-title":"Br. J. Haematol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1159\/000338183","article-title":"Primary effusion lymphoma with central nervous system involvement in an HIV-negative homosexual male","volume":"128","author":"Harris","year":"2012","journal-title":"Acta Haematol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/cup.12368","article-title":"Extracavitary primary effusion lymphoma presenting as a cutaneous tumor: A case report and literature review","volume":"41","author":"Pielasinski","year":"2014","journal-title":"J. Cutan. Pathol."},{"key":"ref_71","first-page":"6124325","article-title":"A rare case of extracavitary primary effusion lymphoma in the bladder and ureter","volume":"2020","author":"Tong","year":"2020","journal-title":"Case Rep. Hematol."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Zanelli, M., Sanguedolce, F., Palicelli, A., Zizzo, M., Martino, G., Caprera, C., Fragliasso, V., Soriano, A., Valle, L., and Ricci, S. (2021). EBV-driven lymphoproliferative disorders and lymphomas of the gastrointestinal tract: A spectrum of entities with a common denominator (Part 2). Cancers, 13.","DOI":"10.3390\/cancers13184527"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"e252","DOI":"10.1200\/JCO.2009.26.0398","article-title":"Gross hematopyuria presenting as a first symptom due to bladder infiltration of extranodal Burkitt\u2019s lymphoma","volume":"28","author":"Fujiwara","year":"2010","journal-title":"JCO"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/S0022-5347(05)65316-5","article-title":"Primary Burkitt\u2019s lymphoma of bladder in patient with AIDS","volume":"167","author":"Mearini","year":"2002","journal-title":"J. Urol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1182\/blood-2007-01-041871","article-title":"How I treat patients with Diffuse large B-cell lymphoma","volume":"110","author":"Armitage","year":"2007","journal-title":"Blood"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1056\/NEJMra2027612","article-title":"Diffuse large B-cell lymphoma","volume":"384","author":"Sehn","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"6051","DOI":"10.1002\/cam4.1875","article-title":"Clinicopathological analysis of primary intestinal diffuse large B-cell lymphoma: Prognostic evaluation of CD5, PD-L1 and Epstein-Barr virus on tumor cells","volume":"7","author":"Ishikawa","year":"2018","journal-title":"Cancer Med."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Palicelli, A., Bonacini, M., Croci, S., Magi-Galluzzi, C., Canete-Portillo, S., Chaux, A., Bisagni, A., Zanetti, E., De Biase, D., and Melli, B. (2021). What do we have to know about PD-L1 expression in prostate cancer? A systematic literature review. Part 1: Focus on immunohistochemical results with discussion of preanalyticaland interpretation variables. Cells, 10.","DOI":"10.3390\/cells10113166"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1182\/bloodadvances.2018020602","article-title":"PD-L1 and tumor-associated macrophages in de novo DLBCL","volume":"3","author":"McCord","year":"2019","journal-title":"Blood Adv."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1182\/blood-2015-02-629600","article-title":"Expression of programmed cell death ligand 1 is associated with poor overall survival in patients with diffuse large B-cell lymphoma","volume":"126","author":"Kiyasu","year":"2015","journal-title":"Blood"}],"container-title":["Current Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1718-7729\/29\/2\/81\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:17:31Z","timestamp":1760134651000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1718-7729\/29\/2\/81"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,10]]},"references-count":80,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,2]]}},"alternative-id":["curroncol29020081"],"URL":"https:\/\/doi.org\/10.3390\/curroncol29020081","relation":{},"ISSN":["1718-7729"],"issn-type":[{"value":"1718-7729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,10]]}}}